[

A photo illustration depicting gene editing. Using its new ProGen3 AI model, biotech startup Profluent has developed new gene editing proteins that may be more effective than the CRISPR-Cas9 systems that underpin most contemporary gene editing therapies.
Photo illustration—Getty Images
https://fortune.com/img-assets/wp-content/uploads/2025/04/GettyImages-1359391658_89f21f-e1744742272513.jpg?resize=1200,600
https://fortune.com/2025/04/16/biotech-profluent-ai-scaling-laws-protein-design-models-opencrispr-openantibodies/
Jeremy Kahn